Therapeutic use of chardonnay seed products
US-2019269748-A1 · Sep 5, 2019 · US
Pinot noir grape products for nonalcoholic fatty liver disease and other uses
US10894073B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10894073-B2 |
| Application number | US-201816159922-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 15, 2018 |
| Priority date | Dec 20, 2014 |
| Publication date | Jan 19, 2021 |
| Grant date | Jan 19, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Embodiments described herein provide for uses of grape products, such as Chardonnay and Pinot Noir grape products and grape seed flour, for use in promoting a healthy liver, promoting healthy fat content in a liver, for treating or preventing NAFLD, and other embodiments and uses as described herein.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) in a mammal in need thereof, comprising administering to the mammal an amount of a Pinot Noir grape seed flour effective to treat NAFLD or NASH. 2. The method of claim 1 , wherein the Pinot Noir grape seed flour reduces the amount of fat deposited in the liver. 3. The method of claim 1 , wherein the Pinot Noir grape seed flour is administered in effective amount to treat NAFLD or NASH of about 1 mg to about 15,000 mg. 4. The method of claim 1 , wherein the mammal is a human, companion animal, domestic pet, husbanded animal, or livestock. 5. The method of claim 1 , wherein the method further comprises at least one additional compound. 6. The method of claim 5 , wherein the at least one additional compound is an antioxidant, an anti-cholesterol medication, anti-glycemic compound, or an insulin sensitizer. 7. The method of claim 5 , wherein the at least one additional compound is vitamin E, vitamin A, vitamin C, a carotenoid, lipoic acid, ubiquinol, ubiquinone, or glutathione.
Assignees
Inventors
Classifications
Free radical scavengers or antioxidants · CPC title
for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics · CPC title
Polygonaceae (Buckwheat family), e.g. spineflower or dock · CPC title
Pueraria (kudzu) · CPC title
Papaveraceae (Poppy family), e.g. bloodroot · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10894073B2 cover?
- Embodiments described herein provide for uses of grape products, such as Chardonnay and Pinot Noir grape products and grape seed flour, for use in promoting a healthy liver, promoting healthy fat content in a liver, for treating or preventing NAFLD, and other embodiments and uses as described herein.
- Who is the assignee on this patent?
- Sonomaceuticals Llc, Us Agriculture
- What technology area does this patent fall under?
- Primary CPC classification A61K36/87. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).